Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins

Journal of Virology

Volumn 86, Issue 4, 2012, Pages 2031-2044

  Azab, Walid ^a,b   Osterrieder, Nikolaus ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Zagazig University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GLYCOPROTEIN D; INTEGRIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VITRONECTIN RECEPTOR;

ANIMAL CELL; ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; EPITHELIUM CELL; EQUINE HERPES VIRUS; FETUS; FIBROBLAST; HOST CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; VIRAL TROPISM; VIRUS ENTRY; VIRUS REPLICATION;

ANIMALS; CELL LINE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, EQUID; HERPESVIRUS 4, EQUID; HORSE DISEASES; HORSES; HOST SPECIFICITY; INTEGRINS; VIRAL ENVELOPE PROTEINS; VIRAL TROPISM;

EQUID HERPESVIRUS 1; EQUID HERPESVIRUS 4; EQUIDAE;

EID: 84857100437     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06555-11     Document Type: Article

References (80)

1. Ahrens IG, et al. 2006. Evidence for a differential functional regulation of the two beta(3)-integrins alpha(V)beta(3) and alpha(IIb)beta(3). Exp. Cell Res. 312:925-937.
2. Akula SM, Pramod NP, Wang FZ, Chandran B. 2002. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcomaassociated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108:407-419.
3. Allen GP, Breathnach CC. 2006. Quantification by real-time PCR of the magnitude and duration of leucocyte-associated viraemia in horses infected with neuropathogenic vs. non-neuropathogenic strains of EHV-1. Equine Vet. J. 38:252-257.
4. Allen GP, Bryans JT. 1986. Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Prog. Vet. Microbiol. Immunol. 2:78-144.
5. Allen GP, Yeargan MR. 1987. Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J. Virol. 61:2454-2461.
6. Awan AR, Chong YC, Field HJ. 1990. The pathogenesis of equine herpesvirus type 1 in the mouse: a new model for studying host responses to the infection. J. Gen. Virol. 71(Pt 5):1131-1140.
7. Azab W, et al. 2009. Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome. Arch. Virol. 154: 833-842.
8. Azab W, et al. 2010. Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents. Antiviral Res. 85:389-395.
9. Azab W, et al. 2010. Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate. Virus Res. 151:1-9.
10. Azmi M, Field HJ. 1993. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model. J. Gen. Virol. 74:2339-2345.
11. Bergelson JM, Shepley MP, Chan BM, Hemler ME, Finberg RW. 1992. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718-1720.
12. Blystone SD, Graham IL, Lindberg FP, Brown EJ. 1994. Integrin alpha v beta 3 differentially regulates adhesive and phagocytic functions of the fibronectin receptor alpha 5 beta 1. J. Cell Biol. 127:1129-1137.
13. Campadelli-Fiume G, et al. 2007. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev. Med. Virol. 17:313-326.
14. Campadelli-Fiume G, Menotti L. 2007. Entry of alphaherpesviruses into the cell, p 93-111. In Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (ed), Human herpesviruses: biology, therapy, and immunoprophylaxis. Cambridge University Press, Cambridge, United Kingdom.
15. Carfi A, et al. 2001. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 8:169-179.
16. Chesnokova LS, Nishimura SL, Hutt-Fletcher LM. 2009. Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8. Proc. Natl. Acad. Sci. U. S. A. 106:20464-20469.
17. Clark EA, Brugge JS. 1995. Integrins and signal transduction pathways: the road taken. Science 268:233-239.
18. Cocchi F, et al. 2004. The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry. Proc. Natl. Acad. Sci. U. S. A. 101:7445-7450.
19. Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. 2011. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat. Rev. Microbiol. 9:369-381.
20. Connolly SA, et al. 2003. Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface. J. Virol. 77:8127-8140.
21. Crabb BS, Studdert MJ. 1995b. Equine herpesviruses 4 (equine rhinopneumonitis virus) and 1 (equine abortion virus). Adv. Virus Res. 45:153-190.
22. Csellner H, et al. 2000. EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Arch. Virol. 145:2371-2385.
23. Davison AJ, et al. 2009. The order Herpesvirales. Arch. Virol. 154: 171-177.
24. Flowers CC, O'Callaghan DJ. 1992. Equine herpesvirus 1 glycoprotein D: mapping of the transcript and a neutralization epitope. J. Virol. 66:6451-6460.
25. Foster TP, Kousoulas KG. 1999. Genetic analysis of the role of herpes simplex virus type 1 glycoprotein K in infectious virus production and egress. J. Virol. 73:8457-8468.
26. Fox G, et al. 1989. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70(Pt 3):625-637.
27. Frampton AR, Jr, et al. 2005. Equine herpesvirus 1 utilizes a novel herpesvirus entry receptor. J. Virol. 79:3169-3173.
28. Frampton AR, Jr, et al. 2007. Equine herpesvirus 1 enters cells by two different pathways, and infection requires the activation of the cellular kinase ROCK1. J. Virol. 81:10879-10889.
29. Galdiero M, et al. 1997. Site-directed and linker insertion mutagenesis of herpes simplex virus type 1 glycoprotein H. J. Virol. 71:2163-2170.
30. Geraghty RJ, Krummenacher C, Cohen GH, Eisenberg RJ, Spear PG. 1998. Entry of alphaherpesviruses mediated by poliovirus receptor-related protein 1 and poliovirus receptor. Science 280:1618-1620.
31. Gianni T, et al. 2010. Herpes simplex virus glycoproteins H/L bind to cells independently of αVβ3 integrin and inhibit virus entry, and their constitutive expression restricts infection. J. Virol. 84:4013-4025.
32. Graham KL, et al. 2005. Rotaviruses interact with alpha4beta7 and alpha4beta1 integrins by binding the same integrin domains as natural ligands. J. Gen. Virol. 86:3397-3408.
33. Hamidpour M, Behrendt M, Griffiths B, Partridge L, Lindsey N. 2006. The isolation and characterisation of antiplatelet antibodies. Eur. J. Haematol. 76:331-338.
34. Hasebe R, et al. 2009. Infectious entry of equine herpesvirus-1 into host cells through different endocytic pathways. Virology 393:198-209.
35. Heldwein EE, Krummenacher C. 2008. Entry of herpesviruses into mammalian cells. Cell. Mol. Life Sci. 65:1653-1668.
36. Hynes RO. 2002. Integrins: bidirectional, allosteric signaling machines. Cell 110:673-687.
37. Israel BA, Schultz KT, Murphy CJ. 1998. Lack of detectable interaction between HSV-1 and integrins or tachykinins. Intervirology 41:132-134.
38. Komoriya A, et al. 1991. The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J. Biol. Chem. 266:15075-15079.
39. Krummenacher C, et al. 2004. Comparative usage of herpesvirus entry mediator A and nectin-1 by laboratory strains and clinical isolates of herpes simplex virus. Virology 322:286-299.
40. Kurtz BM, Singletary LB, Kelly SD, Frampton AR, Jr. 2010. Equus caballus major histocompatibility complex class I is an entry receptor for equine herpesvirus type 1. J. Virol. 84:9027-9034.
41. Kydd JH, Smith KC, Hannant D, Livesay GJ, Mumford JA. 1994. Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular immunity. Equine Vet. J. 26:470-473.
42. Lazear E, et al. 2008. Engineered disulfide bonds in herpes simplex virus type 1 gD separate receptor binding from fusion initiation and viral entry. J. Virol. 82:700-709.
43. MacEachern KE, Smith GL, Nolan AM. 1997. Methods for the isolation, culture and characterisation of equine pulmonary artery endothelial cells. Res. Vet. Sci. 62:147-152.
44. Maeda K, et al. 2007. Establishment of a novel equine cell line for isolation and propagation of equine herpesviruses. J. Vet. Med. Sci. 69:989-991.
45. Manoj S, Jogger CR, Myscofski D, Yoon M, Spear PG. 2004. Mutations in herpes simplex virus glycoprotein D that prevent cell entry via nectins and alter cell tropism. Proc. Natl. Acad. Sci. U. S. A. 101:12414-12421.
46. Matsumura T, Sugiura T, Imagawa H, Fukunaga Y, Kamada M. 1992. Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations. J. Vet. Med. Sci. 54:207-211.
47. Montgomery RI, Warner MS, Lum BJ, Spear PG. 1996. Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427-436.
48. Neubauer A, Beer M, Brandmuller C, Kaaden OR, Osterrieder N. 1997. Equine herpesvirus 1 mutants devoid of glycoprotein B or M are apathogenic for mice but induce protection against challenge infection. Virology 239:36-45.
49. Neubauer A, Braun B, Brandmuller C, Kaaden OR, Osterrieder N. 1997. Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. Virology 227:281-294.
50. Neubauer A, Osterrieder N. 2004. Equine herpesvirus type 1 (EHV-1) glycoprotein K is required for efficient cell-to-cell spread and virus egress. Virology 329:18-32.
51. Nugent J, et al. 2006. Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. J. Virol. 80:4047-4060.
52. Osterrieder N. 1999. Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. Virus Res. 59:165-177.
53. Osterrieder N, Van de Walle GR. 2010. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome. Vet. Microbiol. 143:21-28.
54. Palfi V, Christensen LS. 1995. Analyses of restriction fragment patterns (RFPs) and pathogenicity in baby mice of equine herpesvirus 1 and 4 (EHV-1 and EHV-4) strains circulating in Danish horses. Vet. Microbiol. 47:199-204.
55. Patel JR, Heldens J. 2005. Equine herpesviruses 1 (EHV-1) and 4 (EHV- 4)-epidemiology, disease and immunoprophylaxis: a brief review. Vet. J. 170:14-23.
56. Pusterla N, et al. 2005. Equine herpesvirus-4 kinetics in peripheral blood leukocytes and nasopharyngeal secretions in foals using quantitative realtime TaqMan PCR. J. Vet. Diagn. Invest. 17:578-581.
57. Roivainen M, et al. 1994. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 203:357-365.
58. Roizman B. 1996. Herpesviridae, p 2221-2230. In Field BN, Knipe DM, Howley PM, Channock RM, Melnick JL, Monath TP, Roizman B, Straus SE (ed), Virology, third ed. Lippincott-Raven, Philadelphia, PA.
59. Rudolph J, O'Callaghan DJ, Osterrieder N. 2002. Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). J. Vet. Med. B Infect. Dis. Vet. Public Health 49:31-36.
60. Ruoslahti E, Pierschbacher MD. 1987. New perspectives in cell adhesion: RGD and integrins. Science 238:491-497.
61. Sasaki M, et al. 2011. Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D. Genes Cells 16:343-357.
62. Shukla D, et al. 1999. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99:13-22.
63. Smith KC, Mumford JA, Lakhani K. 1996. A comparison of equid herpesvirus-1 (EHV-1) vascular lesions in the early versus late pregnant equine uterus. J. Comp. Pathol. 114:231-247.
64. Spear PG. 2004. Herpes simplex virus: receptors and ligands for cell entry. Cell Microbiol. 6:401-410.
65. Takada Y, Ye X, and Simon S. 2007. The integrins. Genome Biol. 8:215.
66. Telford EA, Watson MS, Perry J, Cullinane AA, Davison AJ. 1998. The DNA sequence of equine herpesvirus-4. J. Gen. Virol. 79:1197-1203.
67. Tischer BK, von Einem J, Kaufer B, Osterrieder N. 2006. Two-step red-mediated recombination for versatile high-efficiency markerlessDNA manipulation in Escherichia coli. Biotechniques 40:191-197.
68. Van de Walle GR, Peters ST, Van der Ven BC, O'Callaghan DJ, and Osterrieder N. 2008. Equine herpesvirus 1 entry via endocytosis is facilitated by alphaV integrins and an RSD motif in glycoprotein D. J. Virol. 82:11859-11868.
69. Verheyen K, et al. 1998. Possible case of EHV-4 ataxia in warmblood mare. Vet. Rec. 143:456.
70. von Einem J, Smith PM, Van de Walle GR, O'Callaghan DJ, Osterrieder N. 2007. In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). Virology 362:151-162.
71. Wang D, Shenk T. 2005. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc. Natl. Acad. Sci. U. S. A. 102:18153-18158.
72. Warner MS, et al. 1998. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246:179-189.
73. Wellington JE, Gooley AA, Love DN, Whalley JM. 1996. N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence for internal cleavage of the gene 71 product. J. Gen. Virol. 77(Pt 1): 75-82.
74. Wellington JE, Love DN, Whalley JM. 1996. Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion. Arch. Virol. 141: 167-175.
75. Whalley JM, et al. 2007. Host cell tropism of equine herpesviruses: glycoprotein D of EHV-1 enables EHV-4 to infect a non-permissive cell line. Arch. Virol. 152:717-725.
76. Whalley M, et al. 1991. Identification and comparative sequence analysis of a gene in equine herpesvirus 1 with homology to the herpes simplex virus glycoprotein D gene. Virus Genes 5:313-325.
77. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. 1993. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell 73:309-319.
78. Wilson WD. 1997. Equine herpesvirus 1 myeloencephalopathy. Vet. Clin. North Am. Equine Pract. 13:53-72.
79. Yoon M, Spear PG. 2004. Random mutagenesis of the gene encoding a viral ligand for multiple cell entry receptors to obtain viral mutants altered for receptor usage. Proc. Natl. Acad. Sci. U. S. A. 101:17252-17257.
80. Ziegler C, Just FT, Lischewski A, Elbers K, Neubauer A. 2005. A glycoprotein M-deleted equid herpesvirus 4 is severely impaired in virus egress and cell-to-cell spread. J. Gen. Virol. 86:11-21.